Independent newsroomEvidence-ranked longevity and peptide reportingHow we report
01

Primary sources first

Regulatory records, full papers, trial registrations, filings and direct documentation outrank summaries and press releases.

02

Evidence before enthusiasm

Cell and animal results are labeled preclinical. Biomarkers are not presented as proof of longer life or better health.

03

No treatment instructions

We do not publish personalized protocols, dosing instructions or sourcing directions for unapproved products.

04

Claims travel with limits

Sample size, study design, conflicts, endpoint relevance and uncertainty appear beside the claim—not buried below it.

05

AI is disclosed

AI may monitor, research, organize sources and write articles. Publisher-authorized automation may publish after the documented sourcing, length, chronology and evidence gates pass.

06

Money is visible

Sponsors, affiliate relationships, investor positions, gifts and material conflicts are disclosed. Commercial partners do not preview coverage.

AI AUTHORSHIP POLICY

AI participates in a disclosed automated desk.

AI can find candidate stories, assemble source packets, create claim ledgers and write original articles. Publisher-authorized automation may publish without prepublication human review when the article passes the newsroom's sourcing, chronology, originality, evidence-labeling and minimum-length gates. The article record identifies that review state. AI may not invent interviews, conceal uncertainty, convert animal evidence into human advice, or present an unreviewed article as medically approved.

Automatic publication is withheld when:
  • Chronology or a material claim cannot be verified
  • Fewer than two authoritative sources are available
  • No primary source supports the central news event
  • The subject duplicates recent Vitalspan Wire coverage
  • The article would require dosing, treatment or personalized medical instructions